Shares of EKF Diagnostics Holdings plc (LON:EKF – Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 27.74 ($0.35) and traded as low as GBX 27.10 ($0.34). EKF Diagnostics shares last traded at GBX 28.40 ($0.35), with a volume of 169,312 shares trading hands.
EKF Diagnostics Stock Up 4.0 %
The firm has a market cap of £128.86 million, a P/E ratio of 2,840.00 and a beta of 0.57. The company has a debt-to-equity ratio of 1.78, a quick ratio of 1.77 and a current ratio of 4.59. The stock’s 50 day simple moving average is GBX 26.12 and its 200 day simple moving average is GBX 27.74.
EKF Diagnostics Company Profile
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
Recommended Stories
- Five stocks we like better than EKF Diagnostics
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- What Do S&P 500 Stocks Tell Investors About the Market?
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- The Role Economic Reports Play in a Successful Investment Strategy
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
